Targeted deep sequencing identifies rare loss-of-function variants in IFNGR1 for risk of atopic dermatitis complicated by eczema herpeticum
Year: 2015
Type: article
Study design: Observational Study
Institutions: Johns Hopkins University, Johns Hopkins Medicine, National Jewish Health, University of Colorado Denver, Northwestern University, Lurie Children's Hospital, Boston Children's Hospital, Harvard University, University of California San Diego, Oregon Health & Science University, University of Rochester Medicine, University of Rochester
Language: English
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: Colorado Clinical and Translational Science Institute (UL1), G215709867, G475936976, Northwestern University Clinical and Translational Science Institute (NUCATS), G5699117591, G625104578, G6330574630, G7842410115, SEAL (Stopping Atopic dermatitis and ALlergy) Study: Prevent allergy by enhancing the skin barrier, Colorado Clinical and Translational Science Institute (UL1)
OpenAlex ID: W1597449782
